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Abstract
Background: In previous meta-analyses, tea consumption has been associated with lower incidence of type 2 diabetes. It is
unclear, however, if tea is associated inversely over the entire range of intake. Therefore, we investigated the association
between tea consumption and incidence of type 2 diabetes in a European population.
Methodology/Principal Findings: The EPIC-InterAct case-cohort study was conducted in 26 centers in 8 European countries
and consists of a total of 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,835 individuals from a total
cohort of 340,234 participants with 3.99 million person-years of follow-up. Country-specific Hazard Ratios (HR) for incidence
of type 2 diabetes were obtained after adjustment for lifestyle and dietary factors using a Cox regression adapted for a case-
cohort design. Subsequently, country-specific HR were combined using a random effects meta-analysis. Tea consumption
was studied as categorical variable (0, .0-,1, 1-,4, $4 cups/day). The dose-response of the association was further
explored by restricted cubic spline regression. Country specific medians of tea consumption ranged from 0 cups/day in
Spain to 4 cups/day in United Kingdom. Tea consumption was associated inversely with incidence of type 2 diabetes; the HR
was 0.84 [95%CI 0.71, 1.00] when participants who drank $4 cups of tea per day were compared with non-drinkers (plinear
trend=0.04). Incidence of type 2 diabetes already tended to be lower with tea consumption of 1-,4 cups/day (HR=0.93
[95%CI 0.81, 1.05]). Spline regression did not suggest a non-linear association (pnon-linearity=0.20).
Conclusions/Significance: A linear inverse association was observed between tea consumption and incidence of type 2
diabetes. People who drink at least 4 cups of tea per day may have a 16% lower risk of developing type 2 diabetes than non-
tea drinkers.
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Introduction
Increasing our understanding of modifiable lifestyle factors
associated with the development of type 2 diabetes is important, as
the prevalence of diabetes is increasing rapidly [1]. Obesity is a
major risk factor for the development of type 2 diabetes [2], but
dietary factors may also play a role. One dietary factor of interest is
tea consumption. Tea consumption may lower the risk of type 2
diabetes by influencing glucose digestion, glucose uptake, and by
protecting beta-cells from free-radical damage [3–5]. This
beneficial effect may be due to the polyphenols present in tea.
A meta-analysis, including nine cohort studies, reported that
drinking at least 4 cups of tea per day was associated with a 20%
lower risk, whereas drinking .0-,1 or 1–3 cups per day did not
lower the risk of diabetes compared with non-tea drinkers [6]. In
line with this, no association was observed when tea consumption
was studied as continuous variable. This may indicate that the
protective effect of tea is restricted to people with a high tea
consumption, although a potential biological mechanism has not
yet been described.
Studies in which tea consumption is low, therefore, may not
observe an association between tea consumption and risk of type 2
diabetes. This is supported by three out of the four additional
cohort studies, which were published after the meta-analysis [7–
10]. Two of those studies, in which the highest tea consumption
category was relatively low, at least 3 cups per day [7] or at least 2
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consumption and risk of diabetes, whereas one study, in which the
highest tea consumption category was more than 5 cups per day,
observed a substantial lower risk [9]. In contrast, one study did not
observe an association, even though the highest category of tea
consumption included participants who drank at least 4 cups per
day [10]. So, to date it is unclear whether or how tea consumption
is associated with risk of type 2 diabetes.
Therefore, we investigated the association between tea con-
sumption and incidence of type 2 diabetes in European citizens
who were part of the EPIC-InterAct project. The size of the study
is comparable with the meta-analyses reported to date on this topic
[6,11] and provides the opportunity to explore a potential non-
linear association between tea consumption and risk of type 2
diabetes across European countries.
Methods
Ethics statement
The study complied with the Declaration of Helsinki. The
Internal Review Board of the International Agency for Research
on Cancer and the Institutional Review Board of all centers, i.e.,
France, Heidelberg, Postdam, Copenhagen, Aarhus, Asturias,
Granada, San Sebastian, Murcia, Navarro, Cambridge, Oxford,
Imperial, Florence, Milan, Ragusa, Turin, Naples, Bilthoven,
Utrecht, Malmo ¨, and Umea ¨, approved the EPIC study. Written
consent was obtained from each EPIC participant at enrolment
into the study.
Population
The EPIC-InterAct project is a case-cohort study embedded in
the EPIC study. The EPIC study is a prospective study conducted
in 10 European countries [12]. Eight countries also participated in
the EPIC-InterAct project (Spain, Italy, Sweden, France, Den-
mark, Germany, The Netherlands, and United Kingdom), with a
total of 26 centers. The rationale and design of the EPIC-InterAct
project has been described in detail elsewhere [13]. In short, a
center-stratified random sample of 16,835 participants, aged 20–
79 years, was taken as sub-cohort. Subsequently, a number of 548
participants with prevalent diabetes and 133 with unknown
diabetes status were excluded, resulting in 16,154 participants.
After verification of all eligible EPIC participants for diabetes
incidence, 12,403 verified cases were obtained of which 778
belongs to the sub-cohort.
Our analysis included 26,039 participants of the 27,779
participants included in the EPIC-InterAct-project, because we
excluded in consecutive order 117 participants without dietary
data, 619 with unreliable food intake data (top and bottom 1% of
the distribution of energy intake to basal energy requirement
assessed by WHO/FAO/UNU equation including weight and
height) [14], and 955 with missing information about potential
confounders which were included in the final model (289 without
physical activity measurements, 134 without information on
smoking status, 367 without information on educational status,
and 165 without information on body mass index (BMI)).
Furthermore, since few participants from Spain (n=39) and Italy
(n=10) drank $4 cups of tea per day, country-specific hazard
ratios (HR) comparing $4 vs. 0 cups per day could not be
obtained in Spain and Italy. Therefore, those 49 participants were
also excluded.
Dietary intake including tea consumption
Dietary intake over the last 12 months was assessed by country-
specific or center-specific semi-quantitative or quantitative dietary
questionnaires, validated within each country [12]. More infor-
mation about the questionnaires can be found elsewhere [12]. All
questionnaires included at least one question about tea consump-
tion. Each center converted the information about tea consump-
tion into grams per day. For the analysis, tea consumption in
grams per day was divided by 125 to be able to calculate HR by
cups per day. In line with the meta-analysis by Jing et al. [6], the
frequency of tea consumption was divided into 4 categories: 0, .0-
,1, 1-,4, $4 cups per day.
Diabetes incidence
A pragmatic, high sensitivity approach for case ascertainment
was used in order to identify all potential incident type 2 diabetes
cases and excluding all individuals with prevalent diabetes [13].
Briefly, ascertainment of incident diabetes involved a review of the
existing EPIC datasets at each center using multiple sources of
evidence including self-report, hospital admissions, linkage to
primary care registers, linkage to secondary care registers, linkage
to drug registers, and mortality data. Cases in Denmark and
Sweden were not ascertained by self-report, but via diabetes and
pharmaceutical registers. Hence, all ascertained cases were
considered to be verified. To increase the ability to exclude false
negatives for countries other than those from Denmark and
Sweden, we sought further evidence for all cases with information
on incident type 2 diabetes from less than 2 independent sources
which have been described in detail elsewhere [13]. Follow-up was
censored at the date of diagnosis, the 31st of December 2007, or
the date of death, whichever occurred first.
Non-dietary covariates
Socio-demographic and lifestyle information, e.g., age, sex,
education level, smoking status, and physical activity during work
and leisure time [15], was obtained with questionnaires at
baseline.
Questionnaires were also used to obtain information about
diseases of the participant and his family, i.e., history of angina
pectoris (not in The Netherlands, Sweden, and one center in
Germany), history of myocardial infarction, history of stroke (not
in one center in Sweden), presence and/or treatment for
hypertension, presence and/or treatment of hyperlipidemia (not
in one center in Sweden), and family history of type 2 diabetes (not
in Spain, Italy, one center in Germany, and one center in the
United Kingdom).
Information about height and weight was obtained using a
standard protocol during a visit at the research center at baseline
for all participants, except in France and in some of the
participants from one center in the United Kingdom. Self-
reported or corrected height and weight were used in those centers
without measured height and weight [12].
Statistical analysis
The association between tea consumption (0, .0-,1, 1-,4, $4
cups/day) and risk of type 2 diabetes was examined by country
using modified Cox proportional hazard models with age as
underlying time scale. The models were modified for the case-
cohort design according to the Prentice method [16]. In order to
adjust for time to follow-up, age at recruitment (1-year categories)
was included as stratum variable. Summary HR and 95%
confidence intervals (95%CI) were obtained by pooling country-
specific HR using random effects meta-analyses and visualized in
forest plots. Between country heterogeneity was assessed by I
2
statistic, i.e., the percentage of variation in the HR attributable to
between country heterogeneity [17].
Tea and Risk of Type 2 Diabetes
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36910To obtain adjusted country-specific HR, four Cox models were
constructed. Variables included in these models were considered
main potential confounders in the association between tea
consumption and risk of type 2 diabetes based upon literature.
Model 1 included, in addition to tea consumption, four other
covariates: sex, smoking status (never, former, current), physical
activity level (inactive, moderately inactive, moderately active, and
active), and education level (lowest, secondary, and highest).
Model 2 was similar to model 1 with additional adjustments for
energy and intake of seven nutrients: protein (energy-%),
carbohydrates (energy-%), saturated fatty acids (energy-%),
mono-unsaturated fatty acids (energy-%), poly-unsaturated fatty
acids (energy-%), alcohol (0, .0–6, .6–12, .12–24, and .24 g/
d), and fiber (g/d). Model 3 was similar to model 2 with additional
adjustments for intake of drinks: coffee (g/d), juices (g/d), soft-
drinks (g/d), and milk (g/d). Model 4 was similar to model 3 with
additional adjustment for BMI (kg/m
2).
After investigating the association between tea consumption as a
categorical variable and risk of type 2 diabetes, the dose-response
of the association was further explored by studying linear trends
across categories, by restricted cubic spline regression, and by
studying consumption of tea (cups per day) as a continuous
variable. To test for linear trends across categories, the median
value of each category of tea consumption was modeled as a
continuous variable. The restricted cubic spline regression was
performed using SAS Macro RCS, which was also based on the
modified Cox proportional hazard regression. The knots were
located at 1, 4, 7 cups per day and non-tea drinkers were used as
reference group. This analysis was adjusted as described for model
4.
Potential effect modification was investigated by including in the
models an interaction term between tea categories and sex or tea
categories and BMI categories and by studying the association
between tea consumption and risk of type 2 diabetes by sex (men:
n=11,249; women: n=15,030) and by BMI (Normal:
BMI,25.0 kg/m
2: n=8,267; Overweight: BMI$25.0-
,30.0 kg/m
2: n=10,840; Obese: BMI$30.0 kg/m
2: n=6,932).
To investigate the robustness of the associations, sensitivity
analyses were performed by excluding one by one participants for
each of the following diseases at baseline: a history of stroke
(n=261), a history of angina pectoris (n=521), a history of a
myocardial infarction (n=545), hypertension (n=5,682), and
hyperlipidemia (n=4,362). Furthermore, participants with a
family history of diabetes (n=2,928) and who developed type 2
diabetes within 2 years (n=955) were excluded in the sensitivity
analyses. We excluded these participants in the sensitivity analyses,
because they may have changed recently their diet. In centers
which did not obtain information about disease history, partici-
pants were considered as not having the disease at baseline.
Analyses were carried out using the statistical software program
SAS version 9.1, except for the random effects meta-analyses
which were conducted in STATA 11.0. A two-sided p-value#0.05
was considered as statistically significant for all analyses.
Results
Overall, 64% of this European study population reported that
they drank tea. The highest median total tea consumption was
observed in the United Kingdom (3.8 (IQR 3.8–6.8) cups per day);
the lowest in Spain (0.0 (IQR 0-0) cups per day) (Figure 1). The
median total tea consumption among drinkers was 1.2 (IQR 0.3–
3.7) cups per day. In general, participants with higher tea
consumption had a lower BMI, had a higher level of education,
and smoked less (Table 1). Intake of carbohydrate and saturated
fatty acids was higher, whereas intake of mono-saturated fatty
acids was lower across tea categories. Tea drinkers drank less
alcohol, but more coffee, soft drinks, and juices than non-tea
drinkers.
When tea consumption was divided into categories and country-
specific HR were combined, the crude analysis showed that, for all
categories, participants who drank tea had a lower risk of
developing type 2 diabetes compared with non-tea drinkers
(Table 2). The risk estimates for type 2 diabetes in all categories
of tea consumption were attenuated slightly in model 1. Additional
adjustment for the intake of nutrients (model 2) and drinks (model
3) did not affect the risk estimates. Adjustment for BMI (model 4),
however, attenuated the risk estimates further, but risk of type 2
diabetes was still 16% lower in participants drinking at least 4 cups
of tea per day compared with non-tea drinkers (HR$4 cups/d vs.
0=0.84 [95%CI 0.71, 1.00]; plinear trend=0.04). Risk of type 2
diabetes already tended to be lower among participants drinking 1
to 4 cups per day compared with non-tea drinkers (Model 4 HR1-
,4 cups/d vs. 0=0.93 [95%CI 0.81, 1.05]) (Table 2; Figure 2). No
evidence of between country heterogeneity was observed in any
category of tea consumption (Figure 2).
The association was further explored by performing spline
regression and by studying tea consumption as continuous
variable. Cubic spline regression confirmed that risk of type 2
diabetes may be lower with higher intake of tea, although it
suggests that the risk may level off after 5 cups per day (pnon-
linearity=0.20; Figure 3). Since the risk reduction may level off,
the association between tea consumption on a continuous scale
and risk of type 2 diabetes was restricted to participants drinking 5
cups per day or less (n=23,778). This analysis suggested that 1 cup
of tea per day was associated with a 3.1% lower risk, which was
nearly statistically significant (Model 4: HR 0.97 [95%CI 0.94,
1.00], p=0.06).
Stratified analyses showed that effect modification was not
observed for sex (Model 4: pinteraction=0.14: Men:H R $4 cups/d vs.
0=0.89 [95%CI 0.71, 1.10]; Women:H R $4 cups/d vs. 0=0.82
[95%CI 0.58, 1.16]) and for BMI (Model 4: pinteraction=0.26:
BMI,25.0:H R $4 cups/d vs. 0=0.79 [95%CI 0.52, 1.19];
BMI$25.0-,30.0:H R $4 cups/d vs. 0=0.87 [95%CI 0.63, 1.20];
BMI$30.0:H R $4 cups/d vs. 0=0.79 [95%CI 0.59, 1.05]).
None of the sensitivity analyses changed the results substantially
(data not shown).
Discussion
In this large European population, a linear inverse association
was observed between tea consumption and incidence of type 2
diabetes. This significant linear association and the spline
regression suggests that a threshold of drinking at least 4 cups of
tea per day to lower risk of type 2 diabetes does not appear to exist.
Strengths of our analyses included the ability to study the
association between tea consumption and risk of type 2 diabetes in
populations from eight European countries, resulting in a larger
variation of tea consumption than when these countries were
analyzed separately. Our results were also strengthened by the
standardized protocol to verify cases of diabetes among countries
and to process information about lifestyle and dietary factors. As
such, consumption of tea was converted into grams per day for all
countries, through which we were able to standardize cup size
among countries in the analysis.
Our observation that drinking tea was associated inversely with
risk of type 2 diabetes, was in line with the observation of two
published meta-analyses equaling the power of our study [6,11].
We observed a protective association on risk of type 2 diabetes
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[6] also with at least 4 cups per day, and Huxley et al. [11] with at
least 3–4 cups per day. In line with the meta-analysis by Jing et al.,
we observed that tea drinkers who drank ,1 cups per day had a
similar risk of type 2 diabetes as non-tea drinkers. Risk of type 2
diabetes, however, already tended to be lower with 1-,4 cups of
tea per day in our analysis. Together with the results of the spline
regression, our results, therefore, do not support that the protective
effect of tea consumption is restricted to participants reporting the
highest intake of tea. Therefore, even lower doses may reduce risk
of type 2 diabetes.
Our spline regression suggests that the risk reduction leveled off
at around 5 cups per day. Potential mechanisms, however,
explaining the observed plateau around 5 cups per day are not
established. Furthermore, we could not study country-specific
associations between a very high tea consumption (.7 cups per
day) and risk of type 2 diabetes in a sufficient number of people in
our analysis. We already had to exclude Spain and Italy from the
highest tea category, because of small numbers in this category.
The biological mechanism underlying a beneficial effect of tea,
however, is unlikely to differ between Northern and Southern
European countries.
The flavonoids present in tea are of importance, because the
beneficial effect of tea on risk of type 2 diabetes may be
attributable to these components [4,5]. Catechins, theaflavins,
and thearubigins are the most prominent flavonoids in tea. These
flavonoids, predominately epigallocatechin gallate (EGCG), have
been shown to slow down carbohydrate digestion, to inhibit
carbohydrate absorption by competitively binding with the
sodium-glucose transporter-1 (SGLT-1), to increase glucose uptake
in muscle and fat cells by changes in GLUT-4 expression, to
enhance insulin secretion, and to protect beta-cells from free-
radical damage [4,5]. All these pathways can affect glucose
concentrations and, thereby, could explain a beneficial effect of tea
consumption on risk of type 2 diabetes. Most randomized
controlled trials investigating the association between long-term
tea consumption and markers of glucose of insulin metabolism,
however, showed no associations [18–23].
Studies investigating the association between tea consumption
and risk of type 2 diabetes may differ by several factors, such as the
type of tea consumed, the preparation method used, the cup size
used, and the sample size under investigation. The main type of
tea consumed may result in discrepancies among studies and
among countries in our study, because types of tea differ in
chemical composition. Herbal teas may contain less anti-oxidants
than black and green tea, because herbal teas, in contrast to black
or green tea, are not derived from the Camellia Sinensis plant [24].
The difference in anti-oxidant capacity may indicate that the
beneficial effect of drinking tea is stronger for black or green tea
than for herbal tea. It is likely that tea consumption in our study
mainly reflects the intake of black tea, because at the time of
dietary data collection in this study, green tea and herbal tea were
not as popular as black tea in most countries. Unfortunately, we
could not investigate whether the type of tea consumed affects risk
of type 2 diabetes differently, because detailed information about
type of tea was not collected in most countries.
The preparation method used may also result in discrepancies.
The preparation method, including brewing time and substances
added, can influence the amount of flavonoids present in a cup of
tea [25,26] and, consequently, the association between tea
consumption and risk of type 2 diabetes. Studies, therefore, might
find an association at 1-,4 cups of tea per day if the brewing time
is long in general, whereas other studies might not find an
association if the brewing time is short. Since information about
brewing time was lacking in all published studies, including ours, it
was not possible to adjust for brewing time. As brewing time was
not reported in our study, non-differential misclassification of
actual amount of tea consumption could have occurred within
countries. Next to a short brewing time, adding milk may also
lower the bioavailability of flavonoids due to the interaction
between milk proteins and flavonoids present in tea [27]. Five out
of six trials, however, showed that adding milk to tea did not affect
Figure 1. Tea consumption based on data from a food frequency questionnaire in the sub-cohort of the EPIC-InterAct project by
country (n=15,227). Bar represents median (p25–p75); error line represents p5 till p95.
doi:10.1371/journal.pone.0036910.g001
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consumption [26,28–32]. Furthermore, the beneficial effect of tea
consumption on risk of type 2 diabetes may be counterbalanced by
the addition of sugar. Since we did not observe heterogeneity
among countries in our study, we do not think that differences in
preparation methods among countries have influenced our results.
In our study, tea consumption was associated with a healthier
lifestyle, e.g., people who drank tea were more physically active
and smoked less. This may indicate that the inverse association
between tea consumption and risk of type 2 diabetes reflects a
healthier lifestyle rather than tea consumption itself. In our
analysis, however, we tried to disentangle the effect of a healthier
lifestyle from tea consumption by adjusting the HR for a range of
lifestyle and dietary factors, and by excluding people with chronic
diseases at baseline in sensitivity analyses. Inclusion of lifestyle and
dietary factors apart from BMI, however, did not change the risk
Table 1. Characteristics of the sub-cohort of the EPIC-InterAct project by categories of tea consumption (n=15,227).
None .0-,11 - ,4 $4
(cups/day) (cups/day) (cups/day)
(n=5,458) (n=4,032) (n=3,444) (n=2,293)
Age (years) 51.7 (8.6) 51.4 (9.1) 53.0 (9.7) 54.7 (8.8)
Body mass index (kg/m
2) 27.0 (4.3) 25.8 (4.0) 25.5 (4.0) 25.0 (3.8)
Male (%) 40.5 41.3 32.7 33.6
Country (%)
Spain 83.0 7.5 9.5 0
Italy 43.1 44.2 12.8 0
Sweden 33.6 30.5 28.2 7.7
France 36.7 21.1 27.4 15.1
Denmark 17.3 38.8 9.8 34.1
Germany 6.1 39.6 36.5 17.8
Netherlands 8.3 18.7 42.1 31.0
United Kingdom 5.2 8.9 39.0 46.9
Smoking (% current) 31.9 27.5 19.6 18.8
Education level (% high) 13.7 21.7 25.3 28.8
Physical activity (% inactive) 31.6 20.1 20.4 15.6
Hypertension (%) 17.5 19.1 20.3 17.4
Hyperlipidaemia (%)
1 17.9 15.8 17.0 10.3
Family history of diabetes (%)
2 13.9 17.1 16.9 17.9
Stroke (%)
3 0.7 0.9 1.1 0.7
Angina Pectoris (%)
4 1.3 2.4 3.1 2.4
Myocardial infarct (%) 1.1 1.4 1.6 1.7
Dietary intake
Total energy (kcal/d) 2188 (662) 2140 (645) 2067 (591) 2124 (603)
Protein (energy%) 18.0 (3.2) 16.4 (2.8) 16.5 (3.1) 16.6 (2.9)
Fat (energy%) 35.4 (6.1) 34.6 (5.7) 34.6 (5.8) 34.0 (5.6)
Saturated fatty acids 12.4 (3.6) 13.6 (3.3) 13.7 (3.3) 13.8 (3.1)
Mono-unsaturated fatty acids 14.6 (3.7) 13.0 (3.1) 12.3 (3.0) 11.3 (2.2)
Poly-unsaturated fatty acids 5.6 (2.1) 5.2 (1.6) 5.8 (1.8) 5.9 (1.8)
Carbohydrate (energy%) 42.2 (7.2) 44.7 (6.9) 45.1 (6.8) 45.5 (6.7)
Fiber (g/d) 22.7 (8.1) 22.1 (7.4) 22.4 (7.2) 24.6 (8.0)
Alcohol (%.24 g/d) 22.6 19.9 15.1 15.5
Coffee (g/d) 154 (60–400) 400 (130–700) 363 (125–525) 375 (86–500)
Soft drinks (g/d) 0 (0–29) 16 (0–86) 14 (0–90) 16 (0–90)
Juices (g/d) 1 (0–25) 22 (3–94) 40 (4–120) 29 (3–100)
Milk (g/d) 180 (61–300) 138 (25–271) 150 (25–295) 193 (36–387)
Values are expressed as Mean (Standard Deviation), Median (p25–p75), or percentage.
1Based on n=13,345, because information about hyperlipidemia was not collected in one center of Sweden.
2Based on n=8,802, because information about family history of diabetes was not collected in Italy, Spain, one center of Germany, and one center of the United
Kingdom.
3Based on n=14,262, because information about a history of stroke was not collected in one center of Sweden.
4Based on n=10,168, because information about a history of angina was not collected in Sweden, The Netherlands, and one center of Germany.
doi:10.1371/journal.pone.0036910.t001
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e36910Figure 2. Association between tea consumption as a categorical variable (.0-,1 vs. 0, 1-,4 vs. 0, $4 vs. 0 cups/d) based on data
from a food frequency questionnaire and risk of type 2 diabetes (n=26,039). Country-specific Hazard Ratios (HR) and 95% Confidence
Intervals (95%CI) were pooled using random effects meta-analyses. HR were adjusted for sex, smoking status, physical activity level, education level,
intake of energy, protein, carbohydrates, saturated fatty acids, mono-unsaturated fatty acids, poly-unsaturated fatty acids, alcohol, fiber, coffee, juices,
soft-drinks, milk, and body mass index.
doi:10.1371/journal.pone.0036910.g002
Table 2. Hazard Ratios (HR) and 95% confidence intervals (95%CI) for incident type 2 diabetes by categories of tea consumption in
cups per day (n=26,039).
Crude Model 1 Model 2 Model 3 Model 4
N total Cases Median HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
0 9 , 4 9 9 4 , 3 8 9 0 11111
.0-,1 7,060 3,197 0.23 0.89 (0.80, 0.99) 0.93 (0.81, 1.07) 0.96 (0.84, 1.10) 0.97 (0.85, 1.10) 1.03 (0.91, 1.16)
1-,4 5,751 2,437 2.00 0.77 (0.66, 0.90) 0.83 (0.69, 0.99) 0.85 (0.71, 1.01) 0.84 (0.72, 0.98) 0.93 (0.81, 1.05)
$4 3,729 1,518 6.84 0.63 (0.50, 0.80) 0.68 (0.52, 0.90) 0.72 (0.53, 0.96) 0.70 (0.54, 0.90) 0.84 (0.71, 1.00)
p-trend ,0.01 ,0.01 ,0.01 ,0.01 0.04
HR and 95%CI were derived from the modified Cox proportional hazard model by age at baseline and are based on pooled estimates from country specific analyses
using a random effects meta-analysis.
Model 1: sex, smoking status, physical activity level, and education level.
Model 2: additional to model 1: intake of energy, protein, carbohydrates, saturated fatty acids, mono-unsaturated fatty acids, poly-unsaturated fatty acids, alcohol, and
fiber.
Model 3: additional to model 2: intake of coffee, juices, soft-drinks, and milk.
Model 4: additional to model 3: body mass index.
doi:10.1371/journal.pone.0036910.t002
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lifestyle could not be adequately adjusted for due to measurement
error in these factors. Even though inclusion of BMI into the
model attenuated the association between tea consumption and
risk of type 2 diabetes, residual confounding by BMI might also be
present. As BMI could also be considered as intermediate [33],
however, caution should be taken when interpreting the model
including BMI.
Furthermore, the inclusion of only clinical cases of diabetes
rather than undiagnosed cases of diabetes might have limited our
results if the prevalence of undiagnosed cases of diabetes differed
substantially among tea categories. We have no indication,
however, that this differential misclassification in the outcome
was likely.
In conclusion, we observed a linear inverse association between
tea consumption and incidence of type 2 diabetes. People who
drink at least 4 cups of tea per day may have a 16% lower risk of
developing type 2 diabetes than non-tea drinkers. Whether
consumption of all types of tea is associated similarly with lower
risk of type 2 diabetes and whether this association is causal should
be further investigated.
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